Efficacy of Oral Corticosteroids in Preventing Esophageal Stenosis after Large Area Endoscopic Submucosal Tunnel Dissection

WANG Jin, WANG Shu-yan, ZHU Xiao-nan. et al

Abstract

To evaluate the efficacy of oral corticosteroids in preventing esophageal stenosis after large area esophageal endoscopic submucosal tunnel dissection (ESTD). Methods The patients undertook esophageal ESTD were included from January 2014 to January 2018. The inclusion criteria was single lesion of esophageal early esophagus cancer with the extent more than 3/4 of circumferential degree. According to the inclusion time, the patients were divided into the trial group (ESTD + oral corticosteroids) and the control group (simple ESTD). The incidence of the total esophageal stenosis, intractable esophageal stenosis, the remission rate of dysphagia and the period from the dysphagia present were observed and compared in the two groups. Results A total of 101 cases of esophageal ESTD patients were included. There were 48 cases in the trial group, 28 cases of male and 20 cases of female, with an average age of (62.98±7.52) years; 53 cases in the control group, 28 cases of male and 25 cases of female, with an average age of (62.67±8.04) years. The rate of intractable esophageal stenosis in the trial group was lower than that in the control group (6.25% vs. 20.75%, P<0.05). The average endoscopic treatment times in the non-refractory stenosis patients in the trial group were significantly less than those in the control group 〔(1.85±0.27) times vs. (3.24±0.49) times, P<0.05〕, and the occurrence time of esophageal stenosis in the trial group was 51.06 d after ESTD, significantly later than that in the control group (29.12 d, P<0.05). Conclusion Oral corticosteroids can effectively reduce the degree of esophageal stenosis after large area ESTD, as well as the incidence of intractable esophageal stenosis and the number of endoscopic treatment in non-refractory esophageal stenosis patients.

 

Keywords:  Early esophageal cancer, Endoscopic submucosal dissection, Esophageal stenosis, Corticosteroids 

 

Full Text:

PDF


References


ONOS, FUJISHIRO M, NIIMI K. et al. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc, 2009,70(5):860-866.

HUANG R. CAI H, ZHAO X. et al. Efficacy and safety of endoscopic submucosal tunnel dissection for superficial esophageal squamous cell carcinoma; a propensity score matching analysis. Gastrointest Endosc,2017,86(5):831-838.

ZHANG W. ZHAI Y, CHAI N. et al. Single-and double- tunnel endoscopic submucosal tunnel dissection for large superficial esophageal squamous cell neoplasms. Endoscopy. 2018,50(05);505-510.

HASHIMOTOS, К OBAYASHI М, TAKEUCHI М. et al. The efficacy of endoscopic triamcinolone injection for the prevention of esophageal stricture after endoscopic submucosal dissection. Gastrointest Endosc,2011 ,74(6); 1389-1393.

EZOE Y, MUTO M, H OR I MATSU T, et al. Efficacy of preventive endoscopic balloon dilation for esophageal stricture after endoscopic resection. J Clin Gastroenterol, 2011, 45(3): 222-227.

YAMAGUCHI N, ISOMOTO H. NAKAYAMA T. et al. Usefulness of oral prednisolone in the treatment of esophageal stricture after endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Gastrointest Endosc, 2011,73(6):1115-1121.

SATO H, INOUE H, KOBAYASHI Y, et al. Control of severe strictures after circumferential endoscopic submucosal dissection for esophageal carcinoma; oral steroid therapy with balloon dilation or balloon dilation alone. Gastrointest Endosc. 2013,78(2):250-257.

ISOMOTOH, YAMAGUCHI N, MINAMI H, et al. Management of complications associated with endoscopic submucosal dissection/endoscopic mucosal resection for esophageal cancer. Dig Endosc,2013,25(Sl);29-38.

JOO rx KIM GH, ГХ) YOUN PARK JHJ, et al. Longterm outcome after endoscopic submucosal dissection in patients with superficial esophageal squamous cell carcinoma: a single-center study, (jut Liver,2014 ,8(6);612-618.

MI WAT A T, OKA S, TANAKA S, et al. Risk factors for esophageal stenosis after entire circumferential endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma. Surg Endosc,2016,30(9):4049-4056.

MAIER A, TOMASELLI F. GEBHARDF, et al. Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation. Ann Thorac Surg,2000,69(4); 1006-1009.

RATONEJP, BORIESE. CAILLOL F, etui. Oral steroid prophylaxis is effective in preventing esophageal strictures after large endoscopic resection. Ann Gastroenterol,2017.30 (1): 62-66.

HANAOKA N. ISHIHARA R, UEDO N. et al. Refractory strictures despite steroid injection after esophageal endoscopic resection. Endosc Int Open.2016,4(3): E354-E359.

ISHIDA T, MORI ТА Y, HOSHI N, et al. Disseminated nocardiosis during systemic steroid therapy for the prevention of esophageal stricture after endoscopic submucosal dissection. Dig Endosc,2015,27(3) ;388-391.

KIMJH, KIM YJ, AN J, et al. Endoscopic features suggesting gastric cancer in biopsy-proven gastric adenoma with high-grade neoplasia. World J Gastroenterol, 2014, 20 (34):12233-12240.

HULL MJ, MINO-KENUDSON M, NISHIOKA NS, et al. Endoscopic mucosal resection an improved diagnostic procedure for early gastroesophageal epithelial neoplasms. Am J Surg PathoL2006,30(l); 114-118.

SHIMIZU Y. YOSHIDA T, КАТО M,et al. Low-grade dysplasia component in early invasive squamous cell carcinoma of the esophagus. J Gastroenterol Hepatol, 2010, 25(2) :314-318.

SOH JS, LIM H. KANG HS ,et al. Does the discrepancy in histologic differentiation between a forceps biopsy and an endoscopic specimen necessitate additional surgery in early gastric cancer? World J Gastrointest Oncol, 2017, 9(8); 319- 326.oie,33(6) :353-356.

ZHANG W. ZHAI Y, CHAI N. et al. Single- and double¬tunnel endoscopic submucosal tunnel dissection for large superficial esophageal squamous cell neoplasms. Endoscopy, 2017.50(5):505-510.

CHOSJ. CHOI IJ, KIM CG, et al. Risk of high-grade dysplasia or carcinoma in gastric biopsy-proven low-grade dysplasia; an analysis using the Vienna classification. Endoscopy .2011.43(6):465-471.

CEN P. HOFSTETTER WL, CORREA AM, et al. Lymphovascular invasion as a tool to further subclassify Tib esophageal adenocarcinoma. Cancer, 2008, 112 ( 5 ); 1020- 1027.

XU G, ZHANG W, LV Y, et al. Risk factors for under¬diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients. Surg Endosc, 2016,30(7);2716-2722.

NAM KW. SONG KS, LEE HY, et al. Spectrum of final pathological diagnosis of gastric adenoma after endoscopic resection. World J Gastroenterol.2011 ,17(47);5177-5183.

TAKAOM. KAKUSHIMA N. TAKIZAWA K, et al. Discrepancies in histological diagnoses of early gastric cancer between biopsy and endoscopic mucosal resection specimens. Gastric Cancer,2012.15( 1) :01 96.

WIJNHOVEN BP. TRAN KT. ESTERMAN A, et al. An evaluation of prognostic factors and tumor staging of resected carcinoma of the esophagus. Ann Surg. 2007. 245 (5 ) : 717- 725.


Refbacks

  • There are currently no refbacks.